New leads to enhance tagraxofusp efficacy in pDC-AML

Morgane Boichut; Margaux Poussard; Xavier Roussel; Imane Belakri; Sabeha Biichlé; Maxime Fredon; Florian Renosi; Romain Boidot; Olivier Adotevi; Christopher Brooks; Francine Garnache-Ottou; Fanny Angelot Delettre

doi:10.1016/j.bneo.2025.100066

New leads to enhance tagraxofusp efficacy in pDC-AML

Morgane Boichut, Margaux Poussard, Xavier Roussel, Imane Belakri, Sabeha Biichlé, Maxime Fredon, Florian Renosi, Romain Boidot, Olivier Adotevi, Christopher Brooks, Francine Garnache-Ottou, Fanny Angelot Delettre^*

^*Corresponding author for this work

Tumor Immunotherapy and Microenvironment

Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)

Original language	English
Article number	100066
Number of pages	5
Journal	Blood Neoplasia
Volume	2
Issue number	2
DOIs	https://doi.org/10.1016/j.bneo.2025.100066
Publication status	Published - May 2025

Access to Document

10.1016/j.bneo.2025.100066Licence: CC BY-NC-ND

Cite this

@article{c8dfe041170d459a88b5c3fa32ebd636,

title = "New leads to enhance tagraxofusp efficacy in pDC-AML",

author = "Morgane Boichut and Margaux Poussard and Xavier Roussel and Imane Belakri and Sabeha Biichl{\'e} and Maxime Fredon and Florian Renosi and Romain Boidot and Olivier Adotevi and Christopher Brooks and Francine Garnache-Ottou and \{Angelot Delettre\}, Fanny",

year = "2025",

month = may,

doi = "10.1016/j.bneo.2025.100066",

language = "English",

volume = "2",

journal = "Blood Neoplasia",

issn = "2950-3280",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - New leads to enhance tagraxofusp efficacy in pDC-AML

AU - Boichut, Morgane

AU - Poussard, Margaux

AU - Roussel, Xavier

AU - Belakri, Imane

AU - Biichlé, Sabeha

AU - Fredon, Maxime

AU - Renosi, Florian

AU - Boidot, Romain

AU - Adotevi, Olivier

AU - Brooks, Christopher

AU - Garnache-Ottou, Francine

AU - Angelot Delettre, Fanny

PY - 2025/5

Y1 - 2025/5

UR - https://www.scopus.com/pages/publications/105013897326

UR - https://pubmed.ncbi.nlm.nih.gov/40453141/

U2 - 10.1016/j.bneo.2025.100066

DO - 10.1016/j.bneo.2025.100066

M3 - Article

C2 - 40453141

AN - SCOPUS:105013897326

SN - 2950-3280

VL - 2

JO - Blood Neoplasia

JF - Blood Neoplasia

IS - 2

M1 - 100066

ER -

New leads to enhance tagraxofusp efficacy in pDC-AML

Access to Document

Other files and links

Cite this